These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 29641565)

  • 1. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
    PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.
    Hinamoto N; Maeshima Y; Yamasaki H; Nasu T; Saito D; Watatani H; Ujike H; Tanabe K; Masuda K; Arata Y; Sugiyama H; Sato Y; Makino H
    PLoS One; 2014; 9(9):e107934. PubMed ID: 25255225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
    Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
    Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effects of vasohibin-2-targeting peptide vaccine for diabetic nephropathy.
    Nakashima Y; Tanabe K; Mifune T; Nakadoi T; Hayashi H; Nakagami H; Sato Y; Wada J
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F1054-F1065. PubMed ID: 38695075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.
    Nasu T; Maeshima Y; Kinomura M; Hirokoshi-Kawahara K; Tanabe K; Sugiyama H; Sonoda H; Sato Y; Makino H
    Diabetes; 2009 Oct; 58(10):2365-75. PubMed ID: 19587360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
    Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
    J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular injury is exacerbated in diabetic integrin alpha1-null mice.
    Zent R; Yan X; Su Y; Hudson BG; Borza DB; Moeckel GW; Qi Z; Sado Y; Breyer MD; Voziyan P; Pozzi A
    Kidney Int; 2006 Aug; 70(3):460-70. PubMed ID: 16775606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells.
    Kitsunai H; Makino Y; Sakagami H; Mizumoto K; Yanagimachi T; Atageldiyeva K; Takeda Y; Fujita Y; Abiko A; Takiyama Y; Haneda M
    Physiol Rep; 2016 Mar; 4(6):. PubMed ID: 27033449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
    Klemis V; Ghura H; Federico G; Würfel C; Bentmann A; Gretz N; Miyazaki T; Gröne HJ; Nakchbandi IA
    Kidney Int; 2017 Jun; 91(6):1374-1385. PubMed ID: 28159318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.
    Saito D; Maeshima Y; Nasu T; Yamasaki H; Tanabe K; Sugiyama H; Sonoda H; Sato Y; Makino H
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F873-86. PubMed ID: 21228103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model.
    Boonloh K; Lee ES; Kim HM; Kwon MH; Kim YM; Pannangpetch P; Kongyingyoes B; Kukongviriyapan U; Thawornchinsombut S; Lee EY; Kukongviriyapan V; Chung CH
    Eur J Nutr; 2018 Mar; 57(2):761-772. PubMed ID: 28004272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.
    Ichinose K; Maeshima Y; Yamamoto Y; Kinomura M; Hirokoshi K; Kitayama H; Takazawa Y; Sugiyama H; Yamasaki Y; Agata N; Makino H
    Diabetes; 2006 May; 55(5):1232-42. PubMed ID: 16644677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice.
    Craven PA; Melhem MF; Phillips SL; DeRubertis FR
    Diabetes; 2001 Sep; 50(9):2114-25. PubMed ID: 11522679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
    Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
    FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S; Nakamura T
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.